Symbols

HCWB

HCW Biologics·NASDAQ

--(--)

HCWB fundamentals

HCWB Q2 2025 Earnings

HCW Biologics (HCWB) released its earnings on Aug 14, 2025: revenue was 1.31K (YoY -99.79%), missed estimates; EPS was -6.79 (YoY -3672.22%), missed estimates.

Revenue / YoY

1.31K

-99.79%

EPS / YoY

-6.79

-3672.22%

Report date

Aug 14, 2025

Earnings

EPS

Revenue

Revenue & Expenses

HCWB has released its 2025 Q4 earnings report, with revenue of 27.01K, reflecting a YoY change of -93.16%, and net profit of 719.23K, showing a YoY change of 121.32%. The Sankey diagram below clearly presents HCWB's revenue sources and cost distribution.

Key Indicators

HCW Biologics (HCWB) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

HCW Biologics (HCWB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

HCW Biologics (HCWB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

HCW Biologics (HCWB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown